Show simple item record

dc.contributor.authorMacintyre, G
dc.contributor.authorGoranova, TE
dc.contributor.authorDe Silva, D
dc.contributor.authorEnnis, D
dc.contributor.authorPiskorz, AM
dc.contributor.authorEldridge, M
dc.contributor.authorSie, D
dc.contributor.authorLewsley, L-A
dc.contributor.authorHanif, A
dc.contributor.authorWilson, C
dc.contributor.authorDowson, S
dc.contributor.authorGlasspool, RM
dc.contributor.authorLockley, M
dc.contributor.authorBrockbank, E
dc.contributor.authorMontes, A
dc.contributor.authorWalther, A
dc.contributor.authorSundar, S
dc.contributor.authorEdmondson, R
dc.contributor.authorHall, GD
dc.contributor.authorClamp, A
dc.contributor.authorGourley, C
dc.contributor.authorHall, M
dc.contributor.authorFotopoulou, C
dc.contributor.authorGabra, H
dc.contributor.authorPaul, J
dc.contributor.authorSupernat, A
dc.contributor.authorMillan, D
dc.contributor.authorHoyle, A
dc.contributor.authorBryson, G
dc.contributor.authorNourse, C
dc.contributor.authorMincarelli, L
dc.contributor.authorSanchez, LN
dc.contributor.authorYlstra, B
dc.contributor.authorJimenez-Linan, M
dc.contributor.authorMoore, L
dc.contributor.authorHofmann, O
dc.contributor.authorMarkowetz, F
dc.contributor.authorMcNeish, IA
dc.contributor.authorBrenton, JD
dc.date.accessioned2019-08-13T08:26:56Z
dc.date.available2018-06-19
dc.date.available2019-08-13T08:26:56Z
dc.date.issued2018-08-13
dc.identifier.issn1061-4036
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/59041
dc.description.abstractThe genomic complexity of profound copy number aberrations has prevented effective molecular stratification of ovarian cancers. Here, to decode this complexity, we derived copy number signatures from shallow whole-genome sequencing of 117 high-grade serous ovarian cancer (HGSOC) cases, which were validated on 527 independent cases. We show that HGSOC comprises a continuum of genomes shaped by multiple mutational processes that result in known patterns of genomic aberration. Copy number signature exposures at diagnosis predict both overall survival and the probability of platinum-resistant relapse. Measurement of signature exposures provides a rational framework to choose combination treatments that target multiple mutational processes.en_US
dc.format.extent1262 - 1270
dc.language.isoenen_US
dc.publisherNature Research (part of Springer Nature)en_US
dc.relation.ispartofNATURE GENETICS
dc.titleCopy number signatures and mutational processes in ovarian carcinomaen_US
dc.typeArticleen_US
dc.rights.holderCopyright © 2018, Springer Nature
dc.identifier.doi10.1038/s41588-018-0179-8
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000443151300017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue9en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttp://doi.org/10.1038/s41588-018-0179-8
pubs.volume50en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderNew treatments for chemotherapy resistant high grader serous ovarian cancer::CRUKen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record